AVGO vs. SMMT
AVGO (Broadcom Inc.) and SMMT (Summit Therapeutics Inc.) are both stocks. AVGO operates in Semiconductors (Technology), while SMMT operates in Biotechnology (Healthcare). Over the past 10 years, AVGO returned 40.54%/yr vs 6.69%/yr for SMMT. At a 0.12 correlation, their price movements are largely independent.
Performance
AVGO vs. SMMT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AVGO achieves a 10.76% return, which is significantly higher than SMMT's -21.90% return. Over the past 10 years, AVGO has outperformed SMMT with an annualized return of 40.54%, while SMMT has yielded a comparatively lower 6.69% annualized return.
AVGO
- 1D
- -2.69%
- 1M
- -0.04%
- 6M
- 19.77%
- YTD
- 10.76%
- 1Y
- 33.25%
- 3Y*
- 62.78%
- 5Y*
- 54.08%
- 10Y*
- 40.54%
- ALL TIME*
- 40.63%
SMMT
- 1D
- -8.81%
- 1M
- -4.14%
- 6M
- -17.16%
- YTD
- -21.90%
- 1Y
- -50.45%
- 3Y*
- 89.42%
- 5Y*
- 11.29%
- 10Y*
- 6.69%
- ALL TIME*
- 2.76%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
AVGO Broadcom Inc. | $7.07B | $8.48B | $10.45B |
| $54.17M | $58.39M | $81.75M |
AVGO vs. SMMT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
AVGO Broadcom Inc. | 10.76% | 50.63% | 110.49% | 104.18% | -13.27% | 56.48% | 44.88% | 29.05% | 2.18% | 48.19% |
SMMT Summit Therapeutics Inc. | -21.90% | -1.99% | 583.72% | -38.59% | 57.99% | -42.77% | 193.75% | 39.13% | -89.62% | 29.44% |
Correlation
The correlation between AVGO and SMMT is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.17 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.17 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Mar 5, 2015 | 0.12 |
Fundamentals
AVGO:
$1.82T
SMMT:
$10.60B
AVGO:
$6.01
SMMT:
-$1.12
AVGO:
21.24
SMMT:
16.87
AVGO:
$75.47B
SMMT:
$0.00
AVGO:
$50.53B
SMMT:
$0.00
AVGO:
$42.03B
SMMT:
-$640.21M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AVGO vs. SMMT — Risk / Return Rank
AVGO
SMMT
AVGO vs. SMMT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Broadcom Inc. (AVGO) and Summit Therapeutics Inc. (SMMT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AVGO | SMMT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.40 | ||
| Sortino ratioReturn per unit of downside risk | +2.01 | ||
| Omega ratioGain probability vs. loss probability | 1.16 | 0.90 | +0.26 |
| Calmar ratioReturn relative to maximum drawdown | 1.17 | -0.91 | +2.08 |
| Martin ratioReturn relative to average drawdown | 2.37 | -1.30 | +3.68 |
Loading charts...
Drawdowns
AVGO vs. SMMT - Drawdown Comparison
The maximum AVGO drawdown since its inception was -48.30%, smaller than the maximum SMMT drawdown of -95.75%. Use the drawdown chart below to compare losses from any high point for AVGO and SMMT.
Loading charts...
Drawdown Indicators
| AVGO | SMMT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.30% | -95.75% | +47.45% |
Max Drawdown (1Y)Largest decline over 1 year | -28.67% | -55.49% | +26.82% |
Max Drawdown (3Y)Largest decline over 3 years | -41.15% | -64.44% | +23.29% |
Max Drawdown (5Y)Largest decline over 5 years | -41.15% | -91.78% | +50.63% |
Max Drawdown (10Y)Largest decline over 10 years | -48.30% | -95.75% | +47.45% |
Current DrawdownCurrent decline from peak | -20.57% | -62.78% | +42.21% |
Average DrawdownAverage peak-to-trough decline | -8.06% | -57.65% | +49.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.05% | 38.73% | -24.68% |
Volatility
AVGO vs. SMMT - Volatility Comparison
The current volatility for Broadcom Inc. (AVGO) is 12.54%, while Summit Therapeutics Inc. (SMMT) has a volatility of 18.45%. This indicates that AVGO experiences smaller price fluctuations and is considered to be less risky than SMMT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AVGO | SMMT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.54% | 18.45% | -5.91% |
Volatility (6M)Calculated over the trailing 6-month period | 34.10% | 56.03% | -21.93% |
Volatility (1Y)Calculated over the trailing 1-year period | 47.24% | 73.40% | -26.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 43.88% | 185.18% | -141.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.69% | 144.54% | -104.85% |
Dividends
AVGO vs. SMMT - Dividend Comparison
AVGO's dividend yield for the trailing twelve months is around 0.67%, while SMMT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
AVGO Broadcom Inc. | 0.67% | 0.70% | 0.94% | 1.71% | 3.02% | 2.24% | 3.05% | 3.54% | 3.11% | 1.87% | 1.43% | 1.13% |
SMMT Summit Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
AVGO vs. SMMT - Financials Comparison
This section allows you to compare key financial metrics between Broadcom Inc. and Summit Therapeutics Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
AVGO and SMMT have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
SMMT has higher volatility (18.45%) compared to AVGO (12.54%). In terms of maximum drawdown, AVGO dropped -48.30% vs SMMT's -95.75%.
AVGO currently has the higher Sharpe Ratio (0.71 vs -0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AVGO and SMMT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer